Peter Sallade - RCABS MD Director
| AXXA Stock | USD 0.0007 0.0001 12.50% |
Insider
Peter Sallade is MD Director of RCABS Inc
| Phone | 855 285 2285 |
| Web | https://exxegroup.com |
RCABS Management Efficiency
The company has return on total asset (ROA) of 0.0272 % which means that it generated a profit of $0.0272 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0736 %, meaning that it created $0.0736 on every $100 dollars invested by stockholders. RCABS's management efficiency ratios could be used to measure how well RCABS manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Nobuya Urashima | ITOCHU | N/A | |
| Y Nakaki | Marubeni Corp ADR | N/A | |
| Tatsuro Tamura | Sumitomo Corp ADR | N/A | |
| Hirokazu Higashino | Sumitomo Corp ADR | 60 | |
| Takayuki Furuya | Marubeni Corp ADR | 59 | |
| Daisuke Tsuchiya | Marubeni Corp ADR | N/A | |
| Hiroyuki Naka | Itochu Corp ADR | 59 | |
| Yoshiko Matoba | ITOCHU | N/A | |
| Kazuaki Yamaguchi | ITOCHU | N/A | |
| Koji Kashima | Marubeni Corp ADR | 57 | |
| Suguru Amano | ITOCHU | N/A | |
| Hiroyuki Naka | ITOCHU | 59 | |
| Koji Aso | Sumitomo Corp ADR | N/A | |
| Aki Tomita | Sumitomo Corp ADR | N/A | |
| Suguru Amano | Itochu Corp ADR | N/A | |
| Yoshiko Matoba | Itochu Corp ADR | N/A | |
| Nobuya Urashima | Itochu Corp ADR | N/A | |
| Yoshinori Takayama | Sumitomo Corp ADR | N/A | |
| Yasuhiro Yoshida | Sumitomo Corp ADR | N/A | |
| Kazuaki Yamaguchi | Itochu Corp ADR | N/A | |
| Koichi Ariizumi | Marubeni Corp ADR | N/A | |
Management Performance
| Return On Equity | 0.0736 | |||
| Return On Asset | 0.0272 |
RCABS Inc Leadership Team
Elected by the shareholders, the RCABS's board of directors comprises two types of representatives: RCABS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RCABS. The board's role is to monitor RCABS's management team and ensure that shareholders' interests are well served. RCABS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RCABS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Sallade, MD Director | ||
| Anna Ivanchenko, Chief Officer | ||
| Darla Gullons, MD Director | ||
| Eduard Nazmiev, CEO CFO | ||
| Boris Matsokhin, Managing Strategy | ||
| Joanna Filipowska, Head Director |
RCABS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is RCABS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0736 | |||
| Return On Asset | 0.0272 | |||
| Profit Margin | 0.29 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 213.29 M | |||
| Shares Outstanding | 418.44 M | |||
| Price To Earning | 0.41 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 30.51 M | |||
| Gross Profit | 6.64 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in RCABS Pink Sheet
RCABS financial ratios help investors to determine whether RCABS Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RCABS with respect to the benefits of owning RCABS security.